Critical Challenges
During the last three decades, Alzheimer research has not only made remarkable progress in understanding the disease but also has recruited some of the best scientists in the word. The prospect of delaying or preventing the onset of symptoms is feasible and within our grasp. However, this mission must surmount a number of barriers, which contain inadequate funding of research, high cost of clinical studies, lack of appropriate in frastructure, better models, antiquated administrative structure of discovery programs, and arcane decision-making systems for selecting and funding innovative ideas. Additionally, the lack of efficient cultivation techniques stems from many factors that largely remain unknown [104]. Hence, molecular
During the last three decades, Alzheimer research has not only made remarkable progress in understanding the disease but also has recruited some of the best scientists in the word. The prospect of delaying or preventing the onset of symptoms is feasible and within our grasp. However, this mission must surmount a number of barriers, which contain inadequate funding of research, high cost of clinical studies, lack of appropriate in frastructure, better models, antiquated administrative structure of discovery programs, and arcane decision-making systems for selecting and funding innovative ideas. Additionally, the lack of efficient cultivation techniques stems from many factors that largely remain unknown [104]. Hence, molecular